BioMarin Pharmaceutical, Inc. (BMRN)

60.16 -0.98 (-1.60%) USD  |  NASDAQ  |  Dec 24, 16:00
More

BioMarin Pharmaceutical Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade